IP Group
IP Group, founded in 2001 and based in London, is a venture capital investment firm focused on the commercialization of intellectual property from research-intensive institutions. The firm specializes in providing financial, strategic, and commercial expertise to facilitate the development of businesses in sectors such as clean technology, life sciences, and deep technology. By leveraging its extensive industry knowledge and financial acumen, IP Group effectively identifies and manages suitable intellectual property for commercialization, helping to create value for shareholders and partners. The firm has established a strong track record of delivering positive results through its strategic investments and partnerships, thereby enhancing the potential of innovative companies in its portfolio.
Carisma Therapeutics is a biotechnology company based in Philadelphia, Pennsylvania, focused on developing innovative cellular immunotherapies for the treatment of solid tumors. Founded in 2016, the company specializes in engineering chimeric antigen receptor (CAR) macrophages and monocytes, which are types of white blood cells that play a crucial role in the immune response. By harnessing advances in macrophage biology and adoptive cell transfer, Carisma aims to enhance cancer therapies, allowing for more effective treatment options for patients with solid tumors. The company is in the clinical stage of development, working to translate its proprietary technology into transformative therapies for various serious diseases.
Carisma Therapeutics is a biotechnology company based in Philadelphia, Pennsylvania, focused on developing innovative cellular immunotherapies for the treatment of solid tumors. Founded in 2016, the company specializes in engineering chimeric antigen receptor (CAR) macrophages and monocytes, which are types of white blood cells that play a crucial role in the immune response. By harnessing advances in macrophage biology and adoptive cell transfer, Carisma aims to enhance cancer therapies, allowing for more effective treatment options for patients with solid tumors. The company is in the clinical stage of development, working to translate its proprietary technology into transformative therapies for various serious diseases.
TrekIT provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care. Easily assign, date and time tasks, categorize them for when they are due, view cleared tasks and more.
Exyn Technologies, Inc. is a Philadelphia-based company specializing in autonomous aerial robotics, having emerged from the GRASP Laboratory at the University of Pennsylvania. Founded in 2014, the company has developed exynAI, a modular software system that enables pilot-less flights for drones in complex commercial settings. This technology leverages multiple redundant sensors and advanced mapping techniques to facilitate obstacle avoidance and autonomous flight planning, allowing for applications such as underground inspections, inventory management, and construction documentation. Exyn's drones operate without human control or GPS, making them particularly suited for navigating challenging environments and automating hazardous tasks.
Carisma Therapeutics is a biotechnology company based in Philadelphia, Pennsylvania, focused on developing innovative cellular immunotherapies for the treatment of solid tumors. Founded in 2016, the company specializes in engineering chimeric antigen receptor (CAR) macrophages and monocytes, which are types of white blood cells that play a crucial role in the immune response. By harnessing advances in macrophage biology and adoptive cell transfer, Carisma aims to enhance cancer therapies, allowing for more effective treatment options for patients with solid tumors. The company is in the clinical stage of development, working to translate its proprietary technology into transformative therapies for various serious diseases.
Carisma Therapeutics is a biotechnology company based in Philadelphia, Pennsylvania, focused on developing innovative cellular immunotherapies for the treatment of solid tumors. Founded in 2016, the company specializes in engineering chimeric antigen receptor (CAR) macrophages and monocytes, which are types of white blood cells that play a crucial role in the immune response. By harnessing advances in macrophage biology and adoptive cell transfer, Carisma aims to enhance cancer therapies, allowing for more effective treatment options for patients with solid tumors. The company is in the clinical stage of development, working to translate its proprietary technology into transformative therapies for various serious diseases.
Exyn Technologies, Inc. is a Philadelphia-based company specializing in autonomous aerial robotics, having emerged from the GRASP Laboratory at the University of Pennsylvania. Founded in 2014, the company has developed exynAI, a modular software system that enables pilot-less flights for drones in complex commercial settings. This technology leverages multiple redundant sensors and advanced mapping techniques to facilitate obstacle avoidance and autonomous flight planning, allowing for applications such as underground inspections, inventory management, and construction documentation. Exyn's drones operate without human control or GPS, making them particularly suited for navigating challenging environments and automating hazardous tasks.
Exyn Technologies, Inc. is a Philadelphia-based company specializing in autonomous aerial robotics, having emerged from the GRASP Laboratory at the University of Pennsylvania. Founded in 2014, the company has developed exynAI, a modular software system that enables pilot-less flights for drones in complex commercial settings. This technology leverages multiple redundant sensors and advanced mapping techniques to facilitate obstacle avoidance and autonomous flight planning, allowing for applications such as underground inspections, inventory management, and construction documentation. Exyn's drones operate without human control or GPS, making them particularly suited for navigating challenging environments and automating hazardous tasks.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.